东宝生物(300239) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥188,034,307.73, a decrease of 22.23% compared to ¥241,778,598.22 in the same period last year[5] - Net profit attributable to shareholders was ¥19,044,819.05, down 26.64% from ¥25,961,526.88 year-on-year[5] - Basic earnings per share decreased to ¥0.0323, down 26.09% from ¥0.0437 in the same period last year[5] - Net profit for the period was ¥19,044,700.74, down from ¥28,081,767.64, a decrease of approximately 32.3% year-over-year[25] - Total operating revenue decreased to ¥188,034,307.73 from ¥241,778,598.22, a decline of approximately 22.2% year-over-year[24] - Total operating costs decreased to ¥165,982,769.88 from ¥209,838,876.06, representing a reduction of about 20.9% year-over-year[24] Cash Flow - The net cash flow from operating activities was -¥37,532,983.25, a significant decline of 298.94% compared to -¥9,408,089.36 in the previous year[5] - The net cash flow from investing activities was -¥7,885,034.85, a decline of 186.17% compared to ¥9,150,743.28 in the previous year[11] - The net cash flow from financing activities was -¥4,808,713.19, a decrease of 284.78% compared to ¥2,602,340.67 in the previous year, primarily due to share repurchase activities[11] - Cash inflow from operating activities totaled $132.76 million, a decrease of 2.3% from the previous period's $136.28 million[28] - Cash outflow from operating activities increased to $170.29 million, up 16.8% from $145.68 million in the prior period[29] - Net cash flow from operating activities was -$37.53 million, worsening from -$9.41 million year-over-year[29] - Cash inflow from investment activities was $941.57 million, significantly higher than $33.22 million in the previous period[29] - Cash outflow from investment activities rose to $949.46 million, compared to $24.07 million last year[29] - Net cash flow from investment activities was -$7.89 million, a decline from $9.15 million in the prior period[29] - Cash inflow from financing activities increased to $40 million, up from $3 million in the previous period[29] - Cash outflow from financing activities totaled $44.81 million, compared to $0.40 million last year[29] - Net cash flow from financing activities was -$4.81 million, a decrease from $2.60 million in the prior period[29] - The ending cash and cash equivalents balance was $447.83 million, down from $715.79 million in the previous period[29] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,592,174,782.52, a decrease of 1.25% from ¥2,624,919,556.21 at the end of the previous year[5] - Total liabilities decreased to ¥873,847,735.56 from ¥885,496,289.52, a decline of about 1.5%[22] - Non-current liabilities increased to ¥604,607,479.99 from ¥561,724,206.32, an increase of approximately 7.6%[22] - The company reported a decrease in cash and cash equivalents from 532,101,881.48 yuan to 477,954,713.78 yuan[20] - Accounts receivable increased from 206,201,924.73 yuan to 212,619,685.82 yuan, indicating a rise in credit sales[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 22,262[13] - The largest shareholder, Qingdao Guoen Technology Co., Ltd., holds 21.18% of shares, totaling 125,711,022 shares, with 88,000,000 shares pledged[13] - Hainan Bainashengyuan Technology Co., Ltd. holds 5.62% of shares, totaling 33,335,422 shares, with 23,320,000 shares pledged[13] - The top 10 shareholders collectively hold significant stakes, with the first three shareholders accounting for over 29% of total shares[13] - The total number of restricted shares at the end of the period is 3,846,150 shares, with 116,287 shares released from restriction[16] Research and Development - Research and development expenses increased by 41.41% to ¥5,722,250.85, compared to ¥4,046,567.55 in the previous year[10] - Research and development expenses increased to ¥5,722,250.85 from ¥4,046,567.55, an increase of about 41.4% year-over-year[25] Other Information - The company reported a significant increase in long-term borrowings, rising by 111.02% to ¥76,073,833.34 from ¥36,050,000.00[10] - The company recorded a profit from asset disposal of ¥10,571.31, a 103.78% increase compared to a loss of ¥279,378.71 in the previous year[10] - The company has disclosed a share repurchase plan, with further details available on the official website[18] - The report indicates that the company is actively managing its shareholder structure and financial assets to enhance shareholder value[18] - Cash flow from operating activities details not provided in the extracted data[27] - Future outlook and strategic initiatives were not detailed in the provided content[27]